VP3.15, a dual GSK-3β/PDE7 inhibitor, reduces glioblastoma tumor growth though changes in the tumor microenvironment in a PTEN wild-type context

María Castelló-Pons(Universidad Nacional de Educación a Distancia), Sergio Casas‐Tintó(Instituto Cajal)
Neurotherapeutics
March 31, 2025
Cited by 2


Related Papers